A health-economic analysis of porcine islet xenotransplantation

Keyphrases

• Islet Xenotransplantation 100%
• Transplantation 100%
• Quality-adjusted Life Years 100%
• Health Economic Analysis 100%
• Islet Transplantation 66%
• Insulin Therapy 66%
• Porcine Islets 50%
• Cost Savings 50%
• Islet Cells 50%
• Cost-effectiveness 33%
• Type I Diabetes 33%
• Type 1 Diabetes Mellitus (T1DM) 33%
• Older Adults 33%
• Monte Carlo Simulation 33%
• Diabetes Complications 33%
• Xenotransplantation 33%
• Medical Care 33%
• Allotransplantation 33%
• Markov Modeling 33%
• Health Economic Evaluation 33%
• Cumulative Costs 33%
• Trial Data 33%
• University of Minnesota 16%
• Cost Estimation 16%
• Islet 16%
• Insulin 16%
• Patient Demographics 16%
• First Year 16%
• Hypoglycemia Unawareness 16%
• Effectiveness Evaluation 16%
• Graft Function 16%
• Transplant Outcomes 16%
• Diabetes Control 16%
• High Cost 16%
• Cost-effectiveness Analysis 16%
• Sensitivity Analysis 16%
• Adult Age 16%
• Duplication 16%
• Blood Glucose 16%
• Cost Data 16%
• Islet Allotransplantation 16%
• Promising Treatment 16%
• Consumer Price Index 16%
• Human Pancreas 16%
• Ongoing Trials 16%
• Adult Type 16%
• Initial Cost 16%
• Partial Grafts 16%
• Comparison with a Standard 16%
• Triplication 16%
• Pancreas Donor 16%
• Type 1 Diabetes Patients 16%

Medicine and Dentistry

• Xenotransplantation 100%
• Health Care Cost 100%
• Quality Adjusted Life Year 37%
• Insulin Treatment 25%
• Islet Transplantation 18%
• Cost-Effectiveness Analysis 18%
• Insulin Dependent Diabetes Mellitus 18%
• Allograft 18%
• Medical Care 12%
• Arm 12%
• Monte Carlo Method 12%
• Hypoglycemia 6%
• Patient Population 6%
• Complication of Diabetes 6%
• Diabetes Control and Complications Trial 6%
• Islet Cell Transplantation 6%
• Blood Glucose 6%